What is the benefit of early invasive therapy in acute coronary syndromes?
A meta-analysis of contemporary randomized clinical trials has found that early invasive therapy in acute coronary syndromes has the potential to improve clinical outcomes in terms of recurrent myocardial infarction, recurrent ischemia, and death from cardiac causes. Additionally, early invasive therapy has been associated with improved quality of life measures and improved risk stratification. This was demonstrated in a 2006 study by Bavry et al. which found that early invasive therapy was associated with a lower risk of death from cardiac causes, myocardial infarction, and recurrent ischemia at one-year follow-up.  